The Effect of Zoledronic Acid on the Prevention of Bone Loss in Lymphoma Patients Receiving First-line Therapy.
Westin J, Hagemeister F, Thompson MA, Cataldo VD, Toth BB, Sanjorjo P, Bourgeois S, Jimenez C, Murphy WA, Fanale M, Fayad L, Fowler N, Kwak L, McLaughlin P, Neelapu S, Pro B, Rodriguez A, Shah J.
Clin Lymphoma Myeloma. 2009 Dec;9(6):E30.PMID: 19951862 [PubMed - in process]Related articles